![](https://webarchive.library.unt.edu/eot2008/20081102203145im_/http://www.nci.nih.gov/images/spacer.gif) |
¿Preguntas sobre el cáncer?
![](https://webarchive.library.unt.edu/eot2008/20081102203145im_/http://www.nci.nih.gov/images/spacer.gif)
|
1-800-422-6237
(1-800-4-CANCER)
|
![](https://webarchive.library.unt.edu/eot2008/20081102203145im_/http://www.nci.nih.gov/images/spacer.gif)
|
Llame de lunes a viernes de 9:00 a.m. a 4:30 p.m., hora local en Estados Unidos y sus territorios. |
|
![](https://webarchive.library.unt.edu/eot2008/20081102203145im_/http://www.nci.nih.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081102203145im_/http://www.nci.nih.gov/images/spacer.gif)
![](https://webarchive.library.unt.edu/eot2008/20081102203145im_/http://www.nci.nih.gov/images/spacer.gif)
| Sustancia que combina un anticuerpo monoclonal (huN901) con un medicamento contra el cáncer (DM1); está en estudio para tratar ciertos cánceres, como el cáncer de pulmón de células no pequeñas. Los anticuerpos monoclonales son sustancias producidas en el laboratorio que pueden localizar las células cancerosas y unirse a ellas. |
![](https://webarchive.library.unt.edu/eot2008/20081102203145im_/http://www.nci.nih.gov/images/spacer.gif)
![](https://webarchive.library.unt.edu/eot2008/20081102203145im_/http://www.nci.nih.gov/images/gray_spacer.gif)
![](https://webarchive.library.unt.edu/eot2008/20081102203145im_/http://www.nci.nih.gov/images/spacer.gif)
|
![](https://webarchive.library.unt.edu/eot2008/20081102203145im_/http://www.nci.nih.gov/images/spacer.gif) |